Agile Therapeutics Stock Forecast

Agile Therapeutics stock price ended at $0.394 on Monday, after gaining 3.68%.
(Updated on Apr 22, 2024)

AGRX Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, April 01, 2024, and so far it has risen 45.93%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Agile Therapeutics stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.493. On a fall, the stock will find some support from the short-term average at $0.376. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Agile Therapeutics stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.370 and $0.340. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Agile Therapeutics finds support just below today's level at $0.370. If this is broken, then the next support from accumulated volume will be at $0.340 and $0.334.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0260 between high and low, or 7.05%. For the last week the stock has had daily average volatility of 8.79%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (AGRX) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect Agile Therapeutics to open at $0.386, and during the day (based on 14 day Average True Range), to move between $0.328 and $0.460, which gives a possible trading interval of +/-$0.0661 (+/-16.79%) up or down from last closing price. If Agile Therapeutics takes out the full calculated possible swing range there will be an estimated 33.57% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.370 (6.09%) than the resistance at $0.420 (6.64%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Agile Therapeutics stock A Buy?

Agile Therapeutics holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -3.125 Sell Candidate Unchanged

Predicted Opening Price for Agile Therapeutics of Tuesday, April 23, 2024

The predicted opening price is based on yesterday's movements between high, low, and closing price.